The heterogeneity of focal forms of congenital hyperinsulinism

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 1, 2012, Pages

  Ismail, Dunia ^a   Kapoor, Ritika R ^a   Smith, Virpi V ^a   Ashworth, Michael ^a,b   Blankenstein, Oliver ^d   Pierro, Agostino ^a   Flanagan, Sarah E ^c   Ellard, Sian ^c   Hussain, Khalid ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF EXETER   (United Kingdom)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

6 FLUORODOPA F 18; DIAZOXIDE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; OCTREOTIDE;

ABCC8 GENE; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DRUG UPTAKE; GENE; GENE MUTATION; GENETIC HETEROGENEITY; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOGLYCEMIA; MICROSATELLITE MARKER; NUCLEOTIDE SEQUENCE; PANCREAS; PANCREAS RESECTION; PATERNALISM; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT RESPONSE;

ATP-BINDING CASSETTE TRANSPORTERS; DIHYDROXYPHENYLALANINE; DNA MUTATIONAL ANALYSIS; FLUORINE RADIOISOTOPES; GENETIC HETEROGENEITY; HUMANS; INFANT, NEWBORN; LOSS OF HETEROZYGOSITY; MODELS, BIOLOGICAL; PANCREAS; PERSISTENT HYPERINSULINEMIA HYPOGLYCEMIA OF INFANCY; PHENOTYPE; POSITRON-EMISSION TOMOGRAPHY; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECEPTORS, DRUG;

EID: 84855474821     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1628     Document Type: Article

References (19)

1. Rahier J, Guiot Y, Sempoux C 2000 Persistent hyperinsulinaemic hypoglycaemia of infancy: a heterogeneous syndrome unrelated to nesidioblastosis. Arch Dis Child Fetal Neonatal Ed 82:F108-F112
2. Goossens A, Gepts W, Saudubray JM, Bonnefont JP, Nihoul-Fekete, Heitz PU, Klöppel G 1989 Diffuse and focal nesidioblastosis. A clinicopathological study of 24 patients with persistent neonatal hyperinsulinemic hypoglycemia. Am J Surg Pathol 13:766-775
3. Klöppel G, Reinecke-Lüthge A, Koschoreck F 1999 Focal and diffuse β-cell changes in persistent hyperinsulinemic hypoglycemia of infancy. Endocr Pathol 10:299-304
4. Verkarre V, Fournet JC, de Lonlay P, Gross-Morand MS, Devillers M, Rahier J, Brunelle F, Robert JJ, Nihoul-Fékété C, Saudubray JM, Junien C 1998 Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. J Clin Invest 102:1286-1291
5. de Lonlay P, Fournet JC, Rahier J, Gross-Morand MS, Poggi-Travert F, Foussier V, Bonnefont JP, Brusset MC, Brunelle F, Robert JJ, Nihoul-Fékété C, Saudubray JM, Junien C 1997 Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J Clin Invest 100:802-807
6. Damaj L, le Lorch M, Verkarre V, Werl C, Hubert L, Nihoul- FékétéC, Aigrain Y, de Keyzer Y, Romana SP, Bellanne-Chantelot C, de Lonlay P, Jaubert F 2008 Chromosome 11p15 paternal isodisomy in focal forms of neonatal hyperinsulinism. J Clin Endocrinol Metab 93:4941-4947
7. Bellanné-Chantelot C, Saint-Martin C, Ribeiro MJ, Vaury C, Verkarre V, Arnoux JB, Valayannopoulos V, Gobrecht S, Sempoux C, Rahier J, Fournet JC, Jaubert F, Aigrain Y, Nihoul-Fékété C, de Lonlay P 2010 ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism. J Med Genet 47:752-759
8. 18F]-DOPA positron emission tomography. Diabetes 55:13-18
9. 18F]fluoro-L-DOPA PET scan for persistent congenital hyperinsulinism in Japan. Clin Endocrinol (Oxf) 75:342-346
10. Mohnike K, Blankenstein O, Christesen HT, De Lonlay J, Hussain K, Koopmans KP, Minn H, Mohnike W, Mutair A, Otonkoski T, Rahier J, Ribeiro M, Schoenle E, Fékété CN 2006 Proposal for a standardized protocol for 18F-DOPA-PET (PET/CT) in congenital hyperinsulinism. Horm Res 66:40-42
11. Ismail D, Smith VV, de Lonlay P, Ribeiro MJ, Rahier J, Blankenstein O, Flanagan SE, Bellanné-Chantelot C, Verkarre V, Aigrain Y, Pierro A, Ellard S, Hussain K 2011 Familial focal congenital hyperinsulinism. J Clin Endocrinol Metab 96:24-28
12. Nestorowicz A, Wilson BA, Schoor KP, Inoue H, Glaser B, Landau H, Stanley CA, Thornton PS, Clement JP 4th, Bryan J, Aguilar-Bryan L, Permutt MA 1996 Mutations in the sulonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews. Hum Mol Genet 5:1813-1822
13. Kassem SA, Ariel I, Thornton PS, Hussain K, Smith V, Lindley KJ, Aynsley-Green A, Glaser B 2001 p57(KIP2) expression in normal islet cells and in hyperinsulinism of infancy. Diabetes 50:2763-2769
14. Suchi M, MacMullen CM, Thornton PS, Adzick NS, Ganguly A, Ruchelli ED, Stanley CA 2006 Molecular and immunohistochemical analyses of the focal form of congenital hyperinsulinism. Mod Pathol 19:122-129
15. Giurgea I, Sempoux C, Bellanné-Chantelot C, Ribeiro M, Hubert L, Boddaert N, Saudubray JM, Robert JJ, Brunelle F, Rahier J, Jaubert F, Nihoul-Fékété C, de Lonlay P 2006 The Knudson's two-hit model and timing of somatic mutation may account for the phenotypic diversity of focal congenital hyperinsulinism. J Clin Endocrinol Metab 91:4118-4123
16. Glaser B, Hirsch HJ, Landau H 1993 Persistent hyperinsulinemic hypoglycemia of infancy: long-term octreotide treatment without pancreatectomy. J Pediatr 123:644-650
17. Raffo A, Hancock K, Polito T, Xie Y, Andan G, Witkowski P, Hardy M, Barba P, Ferrara C, Maffei A, Freeby M, Goland R, Leibel RL, Sweet IR, Harris PE 2008 Role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazine. J Endocrinol 198:41-49
18. Ericson LE, Håkanson R, Lundquist I 1977 Accumulation of dopamine in mouse pancreatic B-cells following injection of L-DOPA. Localization to secretory granules and inhibition of insulin secretion. Diabetologia 13:117-124
19. de Lonlay P, Simon-Carre A, Ribeiro MJ, Boddaert N, Giurgea I, Laborde K, Bellanné-Chantelot C, Verkarre V, Polak M, Rahier J, Syrota A, Seidenwurm D, Nihoul-Féké té C, Robert JJ, Brunelle F, Jaubert F 2006 Congenital hyperinsulinism: pancreatic [18F] fluoro-L- dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion. J Clin Endocrinol Metab 91:933-940